Mylan S.A.S. Withdraws Its Marketing Authorisation Application For Docetaxel Mylan (docetaxel), Europe

Links shared publicly online about this topic.

  • 1,311
    total visits

Mylan S.A.S. Withdraws Its Marketing Authorisation Application For Docetaxel Mylan (docetaxel), Europe

medicalnewstoday.com —

The European Medicines Agency has been formally notified by Mylan S.A.S. of its decision to withdraw its application for a centralised marketing authorisation for the medicinal product Docetaxel M

View full resource at medicalnewstoday.com

Tags: Cancer, Cancer Medication, Taxotere

  • Share

Most Recently Shared on March 16, 2010 at 12:22 pm By:

mnt_drugapprov MNT Drug Approvals

Mylan S.A.S. Withdraws Its Marketing Authorisation Application For Docetaxel Mylan (docetaxel), Europe http://mnt.to/3yVZ #regulatory

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Cancer News MNT Cancer News

Advertisement